Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission Copy
BIOXYTRAN announced that the University of Georgia confirmed the antiviral PHM23 was to be included amongst other drug candidates in the University's grant submission to the U.S. Department of Agriculture’s (USDA) $100 million Highly Pathogenic Avian Influenza (HPAI) Poultry Innovation Grand Challenge.
May 21, 2025